Pfizer Ltd.

PFIZERHealthcare filings

We hold this company’s filings and have not read the financial statements out of them yet. Every filing on record is listed under filings, and each one opens.

Earnings calls

1 transcript(s)/analyst meet(s) served; 0 document(s) on file are not transcripts (cover letters, duplicates, unresolved) and are excluded. Speaker attribution is shown only where the segmenter attributes ≥ 95% of sentences to management or analysts (0 of 1 documents here); elsewhere sentences render unattributed.

Kind	Date	Period	Served	Attribution rate
TRANSCRIPT	20200806	2020-06-30	yes

PFIZER

files the standard Schedule III statements. Every figure below opens to the filing it was read from; where a figure is not shown, the reason is printed in its place.

Identity


Statement division	general
Scope served	standalone
Panels on this page	4

Market

No split, bonus or consolidation is on record for this company inside the period this price series covers, so the closes need no adjustment.


Last close	4,046.20
52-week range	3998.9 – 5529.5
Return 1M	-14.96%
Return 3M	-9.29%
Return 1Y	-19.16%
Return 3Y	5.41%
Return 5Y	-29.12%
Market capitalisation	not shown — we could not confirm it
Shares outstanding	not shown — we could not confirm it
P/E	not shown — we could not confirm it
P/B	not shown — we could not confirm it
EV/EBITDA	not shown — we could not confirm it

Latest quarter filed — period ending 2026-06-30

In INR crore except per-share figures. `period_id` is the period the filing names for the number; the date beside each cell is when it was filed.


Revenue from operations	653.00
Other income	45.00
Total income	698.00
Cost of materials consumed	105.00
Purchases of stock-in-trade	183.00
Changes in inventories	-48.00
Employee benefit expense	82.00
Finance costs	1.00

Ownership — 2026-06-30, and the change from 2026-03-31

Holder	Per cent	Change
promoter and promoter group	0.64	0.00
institutions foreign	0.02	-0.01
institutions domestic	0.18	0.01
mutual funds	0.13	0.01
public	0.36	0.00

Documents on file

Class	Most recent	On file
TRANSCRIPT	2020-06-30	1

Financial statements

Filed results, standalone, in INR crore except per-share figures. Every figure opens to the filing it was read from. Quarterly and annual columns are the periods the filing itself names, never a document date.

Quarterly results, as filed

Line	2022-06-30	2022-09-30	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31	2024-03-31	2024-06-30	2024-09-30	2024-12-31	2025-06-30	2025-09-30	2025-12-31	2026-03-31	2026-06-30
Revenue from operations	593.00	637.00	622.00	573.00	531.00	575.00	540.00	547.00	563.00	589.00	538.00	603.00	642.00	645.00	629.00	653.00
Other income	18.00	24.00	27.00	31.00	33.00	36.00	36.00	75.00	42.00	43.00	43.00	67.00	42.00	38.00	41.00	45.00
Total income	611.00	662.00	649.00	604.00	565.00	611.00	576.00	622.00	605.00	632.00	581.00	670.00	684.00	683.00	670.00	698.00
Cost of materials consumed	90.00	94.00	90.00	71.00	86.00	84.00	77.00	89.00	58.00	77.00	67.00	89.00	70.00	68.00	83.00	105.00
Purchases of stock-in-trade	174.00	67.00	80.00	151.00	147.00	79.00	149.00	94.00	188.00	81.00	105.00	124.00	221.00	145.00	118.00	183.00
Changes in inventories	-48.00	63.00	47.00	-6.00	-17.00	42.00	-43.00	7.00	-45.00	53.00	24.00	-2.00	-63.00	12.00	20.00	-48.00
Employee benefit expense	92.00	82.00	92.00	65.00	94.00	90.00	89.00	75.00	91.00	101.00	96.00	96.00	95.00	100.00	77.00	82.00
Finance costs	4.00	3.00	4.00	3.00	3.00	3.00	3.00	7.00	2.00	2.00	2.00	3.00	2.00	2.00	2.00	1.00
Depreciation and amortisation	27.00	26.00	26.00	26.00	16.00	15.00	18.00	14.00	15.00	15.00	15.00	14.00	14.00	14.00	15.00	14.00
Other expenses	93.00	99.00	109.00	109.00	111.00	98.00	115.00	93.00	93.00	88.00	99.00	86.00	90.00	92.00	96.00	83.00
Total expenses	431.00	435.00	448.00	420.00	439.00	411.00	408.00	378.00	402.00	416.00	408.00	411.00	429.00	433.00	410.00	421.00
Profit before exceptional items and tax	180.00	226.00	201.00	184.00	126.00	201.00	168.00	244.00	203.00	215.00	172.00	260.00	255.00	250.00	260.00	277.00
Exceptional items	-136.00	189.00	0.00	-20.00	0.00	0.00	8.00	0.00	0.00	0.00	0.00	0.00	0.00	-58.00	9.00	0.00
Profit before tax	43.00	415.00	201.00	165.00	126.00	201.00	176.00	244.00	203.00	215.00	172.00	260.00	255.00	192.00	269.00	277.00
Current tax	26.00	107.00	52.00	66.00	33.00	47.00	29.00	49.00	55.00	60.00	50.00	67.00	65.00	58.00	67.00	71.00
Deferred tax	-15.00	-3.00	-2.00	-31.00	-1.00	4.00	17.00	16.00	-3.00	-3.00	-5.00	0.00	1.00	-8.00	2.00	1.00
Tax expense	11.00	104.00	50.00	35.00	32.00	52.00	46.00	65.00	52.00	57.00	45.00	68.00	66.00	50.00	69.00	72.00
Profit for the period	33.00	311.00	151.00	130.00	94.00	149.00	130.00	179.00	151.00	158.00	128.00	192.00	189.00	142.00	200.00	204.00
Other comprehensive income	-0.00	-0.00	-0.00	4.00	-1.00	-1.00	-1.00	8.00	-1.00	-1.00	-1.00	-1.00	-1.00	2.00	4.00	-1.00
Total comprehensive income	32.00	311.00	150.00	134.00	93.00	148.00	129.00	187.00	150.00	158.00	127.00	191.00	188.00	144.00	204.00	204.00
Earnings per share, basic	7.11	67.99	32.93	28.34	20.44	32.56	27.12	22.33	32.94	34.61	27.89	41.91	41.32	31.01	43.68	44.69
Earnings per share, diluted	7.11	67.99	32.93	28.34	20.44	32.56	27.12	22.33	32.94	0.00	27.89	41.91	0.00	31.01	43.68	44.69

Annual results, as filed

Line	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31	2024-03-31	2025-03-31	2026-03-31
Revenue from operations	2,082.00	2,152.00	2,239.00	2,611.00	2,425.00	2,193.00	2,281.00	2,520.00
Other income	167.00	184.00	81.00	63.00	101.00	181.00	172.00	188.00
Total income	2,249.00	2,336.00	2,320.00	2,674.00	2,526.00	2,374.00	2,454.00	2,708.00
Cost of materials consumed	344.00	345.00	335.00	354.00	345.00	336.00	272.00	310.00
Purchases of stock-in-trade	495.00	484.00	449.00	667.00	472.00	469.00	513.00	608.00
Changes in inventories	-91.00	-37.00	14.00	-73.00	56.00	-12.00	25.00	-34.00
Employee benefit expense	324.00	365.00	361.00	404.00	332.00	348.00	371.00	368.00
Finance costs	1.00	11.00	15.00	10.00	13.00	15.00	8.00	9.00
Depreciation and amortisation	71.00	103.00	109.00	115.00	106.00	62.00	61.00	58.00
Other expenses	445.00	422.00	368.00	424.00	411.00	418.00	359.00	363.00
Total expenses	1,589.00	1,693.00	1,651.00	1,901.00	1,735.00	1,636.00	1,610.00	1,683.00
Profit before exceptional items and tax	660.00	642.00	669.00	773.00	791.00	738.00	843.00	1,025.00
Exceptional items	0.00	0.00	0.00	0.00	33.00	8.00	173.00	-49.00
Profit before tax	660.00	642.00	669.00	773.00	824.00	746.00	1,016.00	976.00
Current tax	244.00	133.00	184.00	218.00	252.00	159.00	264.00	258.00
Deferred tax	-13.00	0.00	-13.00	-58.00	-52.00	36.00	-16.00	-4.00
Tax expense	231.00	133.00	171.00	160.00	200.00	195.00	248.00	253.00
Profit for the period	429.00	509.00	498.00	613.00	624.00	551.00	768.00	722.00
Profit attributable to owners	0.00	—	—	—	—	—	—	—
Profit attributable to non-controlling interests	0.00	—	—	—	—	—	—	—
Other comprehensive income	1.00	-9.00	-1.00	7.00	4.00	5.00	1.00	4.00
Total comprehensive income	430.00	500.00	497.00	620.00	628.00	557.00	768.00	726.00
Earnings per share, basic	93.78	111.28	108.77	133.89	136.38	120.51	167.79	157.92
Earnings per share, diluted	93.78	111.28	108.77	133.89	136.38	120.51	167.79	157.92

Balance sheet, as filed

Line	2022-09-30	2023-03-31	2023-09-30	2024-03-31	2024-09-30	2025-03-31	2025-09-30	2026-03-31
Total assets	3,831.00	4,001.00	4,006.00	4,229.00	4,459.00	4,911.00	4,606.00	4,922.00
Non-current assets	1,486.00	1,476.00	1,457.00	1,459.00	1,404.00	1,398.00	1,129.00	1,119.00
Current assets	2,310.00	2,493.00	2,518.00	2,738.00	3,023.00	3,513.00	3,477.00	3,803.00
Property, plant and equipment	199.00	178.00	164.00	151.00	132.00	172.00	155.00	136.00
Capital work-in-progress	5.00	8.00	9.00	0.00	3.00	8.00	8.00	20.00
Goodwill	527.00	527.00	527.00	527.00	527.00	527.00	527.00	527.00
Other intangible assets	69.00	44.00	39.00	34.00	29.00	24.00	19.00	14.00
Inventories	457.00	418.00	399.00	434.00	455.00	476.00	500.00	473.00
Trade receivables	158.00	152.00	174.00	188.00	228.00	193.00	244.00	182.00
Cash and cash equivalents	94.00	37.00	16.00	112.00	35.00	495.00	205.00	103.00
Total equity and liabilities	3,831.00	4,001.00	4,006.00	4,229.00	4,459.00	4,911.00	4,606.00	4,922.00
Equity	2,916.00	3,207.00	3,273.00	3,596.00	3,751.00	4,217.00	3,848.00	4,203.00
Equity share capital	46.00	46.00	46.00	46.00	46.00	46.00	46.00	46.00
Other equity	2,870.00	3,162.00	3,227.00	3,550.00	3,705.00	4,172.00	3,803.00	4,157.00
Total liabilities	914.00	793.00	733.00	633.00	708.00	694.00	757.00	719.00
Non-current liabilities	150.00	136.00	119.00	87.00	103.00	124.00	112.00	92.00
Current liabilities	764.00	657.00	614.00	547.00	605.00	570.00	646.00	627.00
Borrowings, non-current	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Borrowings, current	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00
Trade payables	195.00	217.00	234.00	166.00	181.00	152.00	218.00	216.00

Cash flow, as filed

Line	2022-09-30	2023-03-31	2023-09-30	2024-03-31	2024-09-30	2025-03-31	2025-09-30	2026-03-31
Net cash from operating activities	41.00	356.00	190.00	257.00	349.00	660.00	599.00	968.00
Net cash from investing activities	312.00	-36.00	-2.00	54.00	-244.00	-71.00	-114.00	-562.00
Net cash from financing activities	-322.00	-346.00	-209.00	-235.00	-182.00	-205.00	-775.00	-798.00
Purchase of property, plant and equipment	6.00	65.00	13.00	19.00	9.00	28.00	10.00	25.00
Net increase in cash	31.00	-26.00	-21.00	75.00	-77.00	383.00	-290.00	-392.00
con:CFO.BEFORE_TAX	336.00	854.00	267.00	411.00	442.00	973.00	435.00	953.00
con:INTEREST_RECEIVED.OPERATING	0.00	0.00	0.00	0.00	0.00	-157.00	0.00	0.00
con:INTEREST_PAID.OPERATING	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
con:DIVIDENDS_RECEIVED.OPERATING	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
con:TAX_PAID.OPERATING	106.00	303.00	77.00	154.00	93.00	156.00	-164.00	-15.00
con:CF_OTHER.OPERATING	-189.00	-195.00	0.00	0.00	0.00	0.00	0.00	0.00
con:INVESTMENTS_PURCHASED	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
con:INVESTMENTS_SOLD	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
con:PPE_DISPOSALS	0.00	1.00	0.00	0.00	0.00	0.00	1.00	1.00
con:CF_INVESTING.SUBSIDIARIES_SOLD	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
con:CF_INVESTING.SUBSIDIARIES_ACQUIRED	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
con:CF_INVESTING.JV_SOLD	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
con:CF_INVESTING.JV_ACQUIRED	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Who owns it

The shareholding pattern filed with the exchange every quarter, as a series. Percentages are of total shares. Each figure names the filing it was read from and the date it was filed.

Holder	2023-03-31	2023-06-30	2023-09-30	2023-12-31	2024-03-31	2024-06-30	2024-09-30	2024-12-31	2025-03-31	2025-06-30	2025-09-30	2025-12-31	2026-03-31	2026-06-30
Promoter and promoter group	63.92	63.92	63.92	63.92	63.92	63.92	63.92	63.92	63.92	63.92	0.64	0.64	0.64	0.64
Domestic institutions	14.89	14.89	15.01	15.15	15.33	15.84	16.03	16.79	17.10	17.23	0.17	0.17	0.17	0.18
Mutual funds	—	—	—	—	—	—	—	—	—	11.70	0.12	0.12	0.12	0.13
Insurance companies	8.89	8.68	7.57	7.52	7.44	7.40	5.52	5.39	5.43	5.45	0.05	0.05	0.05	0.05
Foreign institutions	2.80	2.81	2.82	3.03	3.33	3.22	3.54	2.75	2.18	2.39	0.03	0.03	0.03	0.02
Government	—	—	—	—	—	—	—	—	—	0.00	0.00	0.00	0.00	0.00
Public	36.08	36.08	36.08	36.08	36.08	36.08	36.08	36.08	36.08	36.08	0.36	0.36	0.36	0.36
Non-institutional	18.38	18.37	18.25	17.90	17.42	17.01	16.50	16.54	16.79	16.45	0.16	0.16	0.16	0.17
Shares outstanding	45747732	45747732	45747732	45747732	45747732	45747732	45747732	45747732	45747732	45747732	45747732	45747732	45747732	45747732

Related parties

Transactions with related parties as disclosed to the exchange for the period ending 2024-09-30, by counterparty, largest first. Amounts are as filed. Each row names the filing and the date it was filed.

Counterparty	Relationship	Type	Amount in the period	Transactions
Pfizer Service Company BVBA, Belgium	Fellow Subsidiary	Purchase of goods or services	2,823,100,000.00	1
Pfizer East India BV	Companies holding significant incf	Dividend paid	636,500,000.00	1
Pfizer Worldwide Services Company	Fellow Subsidiary	Sale of goods or services	552,700,000.00	1
Wyeth LLC	Companies holding significant incf	Dividend paid	196,600,000.00	1
Pfizer Products India Private Limited, India	Fellow Subsidiary	Any other transaction, Sale of goods or services	153,700,000.00	2
Wyeth Holdings LLC	Companies holding significant incf	Dividend paid	57,100,000.00	1
Warner-Lambert Company LLC	Companies holding significant incf	Dividend paid	41,600,000.00	1
Meenakshi Nevatia	Key Managerial Personnel	Remuneration	39,600,000.00	1
Parke, Davis & Company LLC	Companies holding significant incf	Dividend paid	33,500,000.00	1
John Wyeth & Brothers Ltd	Companies holding significant incf	Dividend paid	30,900,000.00	1
Pharmacia LLC	Companies holding significant incf	Dividend paid	27,400,000.00	1
Pfizer Healthcare India Private Limited	Fellow Subsidiary	Sale of goods or services	19,600,000.00	1
Amit Agarwal	Key Managerial Personnel	Remuneration	16,000,000.00	1
Pfizer export B.V	Fellow Subsidiary	Sale of goods or services	14,000,000.00	1
P.Rengan	Key Managerial Personnel	Remuneration	4,800,000.00	1

What management said

Every earnings call we hold for this company, read in full. Prepared remarks are separated from the question-and-answer session and every paragraph names who said it and on which page. These are management’s own words, not filed figures.

Date	Quarter	Who spoke
2020-08-06	Q1FY21		Read the call

What they said about it, quarter by quarter

Topic	Q1FY21
Capex	And also want to know, what is your CAPEX plan for next year, including maintenance CAPEX?
Capital allocation	These are two brands, we are talking about Wymox which we divested to Abbott.
Debt and cash	We were lucky to get a very strong supply chain in place, we supported the traders with working capital support, we had a very, very innovative supply…
Demand	Obviously, this portfolio has declined given the low footfalls as you have mentioned, any visible signs of demand building on the hospital side and an…
Margin	And the gross margin improvement because of product mix, if you can add some color to that?